Bluejay Diagnostics (BJDX) FCF Margin (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed FCF Margin for 2 consecutive years, with 2774.52% as the latest value for Q3 2023.

  • Quarterly FCF Margin changed N/A to 2774.52% in Q3 2023 from the year-ago period, while the trailing twelve-month figure was 3295.07% through Dec 2023, down 73409.0% year-over-year, with the annual reading at 742230.04% for FY2025, 74124251.0% up from the prior year.
  • FCF Margin hit 2774.52% in Q3 2023 for Bluejay Diagnostics, down from 1850.58% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 715.67% in Q2 2022 to a low of 3506.51% in Q1 2022.